Standard BioTools
LAB
LAB
138 hedge funds and large institutions have $269M invested in Standard BioTools in 2021 Q1 according to their latest regulatory filings, with 27 funds opening new positions, 43 increasing their positions, 41 reducing their positions, and 34 closing their positions.
Holders
138
Holders Change
-7
Holders Change %
-4.83%
% of All Funds
2.43%
Holding in Top 10
2
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-33.33%
% of All Funds
0.04%
New
27
Increased
43
Reduced
41
Closed
34
Calls
$4.53M
Puts
$6.01M
Net Calls
-$1.47M
Net Calls Change
-$4.11M
Top Buyers
| 1 |
ICM
1
Indaba Capital Management
San Francisco,
California
|
$33.7M |
| 2 |
NIM
2
Needham Investment Management
New York
|
$10.9M |
| 3 |
CPA
3
Cowen Prime Advisors
New York
|
$4.44M |
| 4 |
SC
4
Samjo Capital
New York
|
$3.68M |
| 5 |
O
5
OrbiMed
New York
|
$20.8M |
